These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10649642)

  • 21. "Vulnerable plaques"--ticking of the time bomb.
    Mitra AK; Dhume AS; Agrawal DK
    Can J Physiol Pharmacol; 2004 Oct; 82(10):860-71. PubMed ID: 15573146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute coronary thrombosis].
    Tedgui A; Mallat Z
    Rev Prat; 2003 Mar; 53(6):602-6. PubMed ID: 12749144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current data on atheromatous plaques and their evolution].
    Bauters C; Van Belle E; McFadden E; Bertrand M
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():9-12. PubMed ID: 9833074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plaque disruption and thrombosis: potential role of inflammation and infection.
    Shah PK
    Cardiol Rev; 2000; 8(1):31-9. PubMed ID: 11174871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization.
    Hellings WE; Peeters W; Moll FL; Pasterkamp G
    Trends Cardiovasc Med; 2007 Jul; 17(5):162-71. PubMed ID: 17574124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New insights towards catheter-based identification of vulnerable plaque].
    Rodríguez-Granillo GA; Regar E; Schaar JA; Serruys PW
    Rev Esp Cardiol; 2005 Oct; 58(10):1197-206. PubMed ID: 16238988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Unstable carotid plaque: biochemical and cellular marker of vulnerability].
    Carbone GL; Mauriello A; Christiansen M; Oxvig C; Spagnoli LG; Schwartz RS; Sangiorgi G
    Ital Heart J Suppl; 2003 May; 4(5):398-406. PubMed ID: 12848077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological mechanisms of erythrocyte-induced vulnerability of atherosclerotic plaques.
    Lin HL; Xu XS; Lu HX; Li CJ; Tang MX; Sun HW; Zhang Y
    Med Hypotheses; 2008; 70(1):105-8. PubMed ID: 17601678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics.
    Takano M; Jang IK; Inami S; Yamamoto M; Murakami D; Okamatsu K; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2008 Feb; 101(4):471-6. PubMed ID: 18312760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing an animal model of unstable atherosclerotic plaques.
    Chen WQ; Zhang Y; Zhang M; Ji XP; Yin Y; Zhu YF
    Chin Med J (Engl); 2004 Sep; 117(9):1293-8. PubMed ID: 15377416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment.
    Insull W
    Am J Med; 2009 Jan; 122(1 Suppl):S3-S14. PubMed ID: 19110086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mast cells: multipotent local effector cells in atherothrombosis.
    Kovanen PT
    Immunol Rev; 2007 Jun; 217():105-22. PubMed ID: 17498055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Induction of atherosclerotic plaque instability in rabbits after transfection of human wild-type p53 gene].
    Chen WQ; Zhang Y; Zhang M; Ji XP; Lin C; Zhu YF; Zhang W; Wang R; Liu Y; Yao GH
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):43-7. PubMed ID: 14990158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications.
    Slager CJ; Wentzel JJ; Gijsen FJ; Thury A; van der Wal AC; Schaar JA; Serruys PW
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):456-64. PubMed ID: 16265586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interface of atherosclerosis and thrombosis: basic mechanisms.
    Libby P
    Vasc Med; 1998; 3(3):225-9. PubMed ID: 9892515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there life after plaque rupture?
    Jackson CL
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):887-9. PubMed ID: 17956238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of plaque instability in atherosclerotic vascular disease.
    Rao DS; Goldin JG; Fishbein MC
    Cardiovasc Pathol; 2005; 14(6):285-93. PubMed ID: 16286036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Description and mechanisms of sclerotic arterial diseases of the lower limbs].
    Capron L
    Rev Prat; 1995 Jan; 45(1):25-30. PubMed ID: 7725005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation and plaque vulnerability.
    Shah PK
    Cardiovasc Drugs Ther; 2009 Feb; 23(1):31-40. PubMed ID: 18949542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Present-day investigations cannot adequately determine the risk of acute coronary syndromes.
    Foo RS
    Clin Lab; 2001; 47(5-6):257-63. PubMed ID: 11405604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.